Thousands of medicare patients enrolled in pacemaker safety study
NCT ID NCT04235491
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 37,000 Medicare patients who received a Micra AV leadless pacemaker or a traditional pacemaker to treat slow heart rate (bradycardia). Researchers will compare complication rates and survival over two years using insurance claims data. The goal is to understand how well these newer leadless devices perform in real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University
Atlanta, Georgia, 30308, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new device make pacemaker placement more precise?
- Pacemaker tweak may also lower blood pressure
- Could a pacemaker tame stubborn high blood pressure?
- Freezing or burning heart nerves: which works best for slow heartbeat?
- Pacemaker tweak may lower blood pressure in early test
- Could a simple swaddle ease dangerous reflux in preemies?